Chemical synthesis and catalytic clamp construction. S2
1.1 General. x 100 mL brine solution, dried over Na2SO4 and concentrated to give 6.24 g of a pale brown oil in an overall yield of 54%, containing a minor impurity of the product in which both amines are protected (~10% determined from 1 H-NMR): 
ESI-MS

6-Maleimido caproic acid N-hydroxysuccinimide ester (S3)
5-Maleimido caproic acid (125 mg, 0.59 mmol) and distilled triethylamine (0.12 mL, 0.89 mmol) were dissolved in 10 mL distilled CH2Cl2, after which disuccinimidylcarbonate (DSC, 228 mg, 0.89 mmol) was added and the solution was stirred for 3 h in the dark under a nitrogen flow. The solvent was concentrated in vacuo and subjected to silica column chromatography using ethyl acetate in acetonitrile 50% v/v as eluent. Fractions containing pure product were isolated, dried over MgSO4, filtered and concentrated in vacuo to yield 140 mg (77%) of a colourless oil: Alternatively, an appropriate amount of the ester was prepared using 1.0 eq. DIPEA and 1.0 eq. DSC and used in the next step without purification. and dissolving it in t-butylalcohol (3x) followed by evaporation under reduced pressure. In the third t-BuOH washing step, CH2Cl2 was added. The resulting light brown sticky oil was used immediately in the next step.
ESI-MS
(b) The solid prepared as described under (a) was dissolved in 10 mL distilled CH2Cl2 and made basic by addition of DIPEA (to pH = 10), before addition of the solution of S3 prepared using the DSC method on a 1.22 mmol scale. The resulting solution was stirred overnight under nitrogen in the dark. The solvent was evaporated under reduced pressure and the product was subjected to silica column chromatography (MeOH in EtOAc, 0-8% v/v). Fractions containing the product were isolated, evaporated under reduced pressure and purified with a Biobeads column (eluent: distilled THF)
to remove traces of N-hydroxy succinimide. Pure fractions were concentrated under reduced pressure to yield 320 mg of a light brown oil (62%), which crystallised into a white crystalline powder: 
3-Azidopropanol (S5)
This compound was synthesized according to a literature procedure from 3-chloropropanol, 1 and it was distilled under reduced pressure (bp 47°C at 4 mbar) to yield 74% of a colourless oil: 
Due to its structure, low weight and volatility, no HRMS or elemental analysis could be performed on this compound.
1-Mesyl-3-azidopropane (S6)
A solution of mesyl chloride (4.7 g, 41 mmol) in 40 mL distilled THF was added dropwise to an ice-cooled solution of 3-azidopropanol S5 (4.0 g, 40 mmol) and DIPEA (7.0 mL, 41 mmol) in 40 mL distilled THF, and stirred at 0 °C for 30 min. Then, it was allowed to warm to room 
Propionic acid ester of tripyridylphenoxyporphyrine (S7)
This compound was synthesised according to the Adler method. 
Hydroxy tripyridylphenoxyporphyrine (S8)
The propionic ester of tripyridylporphyrin S7 (105 mg, 0.152 mmol) was saponified by dissolving the compound in a mixture of 15 mL dioxane, 4 mL MeOH and 2 mL 2N NaOH. After stirring the reaction mixture for 30 min in the dark, it was quenched by addition of 5 mL 1N HCl solution. A saturated solution of NaHCO3 was added until the porphyrin precipitated out of the solution. The precipitate was isolated by centrifugation (3700 rpm, 5 min) and washed two times with water followed by centrifugation.
The porphyrin was dried under high vacuum (0.4 mbar) for a prolonged period to yield 92 mg (95%) of a purple crystalline compound which was used immediately in the next reaction: 
Azide functionalised tripyridylphenoxyporphyrine (S9)
Deprotected porphyrin S8 (88 mg, 0.14 mmol) was dissolved in 10 mL DMF, followed by addition of freshly crushed NaOH (56 mg, 1.4 mmol), 
Manganese azide functionalised tripyridylphenoxyporphyrine acetate (S10)
The azide porphyrin S9 (110 mg, 0.153 mmol) was dissolved in 15 mL DMF and heated to 100 °C, after which collidine (0. Alkyne-maleimide linker S4 (11.4 mg, 0.028 mmol, 1.1 eq. compared to porphyrin S10) was placed in a Schlenk reaction vessel, which was deaereated by at least 5 consecutive pump-N2 cycli. Porphyrin S10 (21 mg, 0.025 mmol)
was dissolved in deaereated THF to a concentration of 5 mg/mL, which was again rendered oxygen free by nitrogen sparging for at least 10 min. It was then added to the S4 in the Schlenk vessel. A Cu(I)-catalyst solution was prepared by suspending CuBr (7.2 mg, 0.050 mmol, 2 eq.) in deaereated THF, followed by further nitrogen sparging for at least 10 min. To this mixture, an excess of PMDETA was added to dissolve the CuBr, keeping a constant flow of N2. After all CuBr was dissolved, half of the resulting yellow-green catalyst solution was transferred to the Schlenk vessel with an argon-flushed syringe (final quantity of Cu(I) present: 1 eq. -note that the manganese in the porphyrin precludes copper insertion). The resulting solution was left to react for 14 h, after which it was diluted with CH2Cl2 and extracted with saturated NaHCO3. Any precipitate in the reaction vessel was dissolved in water by addition of a few drops of 1M HCl solution and added to the aqueous phase, which was then extracted twice with CH2Cl2. The organic layers were combined and washed with a 0.3M NaOAc buffer (pH 5.2) supplemented with EDTA, after which they were concentrated in vacuo and precipitated in hexane to yield 24.9 mg (66%) of a green solid: the residue was redissolved in a minimal amount of DMF. It was precipitated in ethyl acetate several times, and extensively dried in high vacuum to yield 32 mg (120%) of a gray shiny oil:
Maldi-TOF MS
No mass data could be obtained with Maldi-TOF or ESI-MS.
UV-Vis (H2O) λ 466, 564, 601 nm;
This compound is paramagnetic, which prohibits its analysis by conventional 1 H-or 13 C-NMR.
For increased certainty about the molecular structure of the paramagnetic reaction products S10, S11 and 2, we synthesised the following zinc porphyrin analogues, which we were able to analyse by 1 H-and 13 C-NMR:
Tritoluylphenoxyporphyrine (S12)
This compound was synthesised according to the Adler method. 2 4-Hydroxybenzaldehyde (4.6 g, 37.5 mmol) and p-tolualdehyde (13.5 g, 113 mmol) were dissolved in 500 mL propionic acid and heated to reflux, followed by addition of freshly distilled pyrrole (10.1 g, 150 mmol). The solution was refluxed for 1.5 h, cooled and allowed to crystallise overnight at 4 °C. The solution was filtered and the residue was washed with ethanol until the filtrate was colourless, after which the solid was dried. It was subsequently purified in 2 g batches with silica
column chromatography (MeOH in CH2Cl2, 0-3% v/v) to yield a total of 1.2 g (5%) of a purple solid: 
Bromopropyl functionalised tritoluylphenoxyporphyrine (S13)
Hydroxyl porphyrin S12 (70 mg, 0.10 mmol) was dissolved in 7 mL DMF, followed by addition of dibromopropane (420 mg, 2.08 mmol) and K2CO3 (58 mg, 0.42 mmol). The solution was stirred overnight at 40 °C under an N2 atmosphere in the dark, after which the solvent was evaporated under reduced pressure. The residue was dissolved in 25 mL CHCl3, extracted three times with 25 mL 5% aqueous KHSO4, two times 25 mL aqueous saturated NaHCO3 and 25 mL saturated NaCl solution.
The organic layer was dried with Na2SO4, concentrated in vacuo, and subjected to silica column chromatography (CH2Cl2) to yield 52 mg (63%) of a purple solid: 
(CH2Br), 30.5, 21.9.
Azidopropyl functionalised tritoluylphenoxyporphyrine (S14)
Bromopropyl functionalised porphyrin S13 (50 mg, 0. 
Zinc azidopropyl functionalised tritoluylphenoxyporphyrine (S15)
Azide porphyrin S14 (25 mg, 0.033 mmol) was dissolved in 10 mL 
Synthesis of octapeptide CSLDFLFG (3)
The peptide was synthesised on 2.8 gr Wang resin (0.67 mmol/g loading) using standard solid phase peptide techniques.
Residue's N-termini were FMOC protected, side chains were protected by Boc (t-butyl oxycarbonyl) for lysine, t-butyl ether or ester groups for serine or aspartic acid, or trityl for cysteine. The peptide was cleaved from the resin using 95% TFA, 2.5% ethanedithiol, and 2.5% H2O, precipitated in ether and lyophilized from acetic acid. 
Maldi-TOF MS
N-(t-Butoxycarbonyl)-O-(carboxymethyl)hydroxylamine (S17)
Carboxymethylhydroxylamine hemihydrochloride (300 mg, 2.75 mmol) was dissolved in 10 mL of dioxane followed by addition of DIPEA (0.60 mL, 3.44 mmol). After the hydroxylamine was dissolved, di-t-butyl-dicarbonate (659 mg, 3.02 mmol) was added and the solution stirred for 16 h under an N2 atmosphere. Then, 50 mL water and a few drops of 1M aqueous NaOH was added to the reaction mixture, which was subsequently extracted with 3x50 mL ethyl acetate.
The aqueous phase was acidified to pH = 3 by addition of 0.5M aqueous KHSO4 and extracted with 3x50 mL ethyl acetate. The combined organic layers were washed with 0.5M KHSO4 and brine, dried over NaSO4 and concentrated.
The product was crystallised from ethyl acetate in heptane 
N-Hydroxysuccinimide ester of N-(t-Butoxycarbonyl)-O-(carboxymethyl)hydroxylamine (S18)
This compound was synthesized following a procedure from Ide et al. 3 Instead of purification by crystallisation, the product was purified using silica column chromatography (acetonitrile in CH2Cl2, 1:1 v/v) to yield 65% of a white crystalline compound, which was used directly in the next reaction: 
ESI-MS
Boc-protected ARP (S19)
The NHS ester S18 (43 mg, 0.15 mmol) was dissolved in dry DMF (1 mL), and biotin hydrazide (32 mg, 0.12 mmol) and one drop of DIPEA were added. The reaction mixture was stirred for 16 
ARP reagent (4)
Boc-protected ARP S19 (25.4 mg, 0.059 mmol) was dissolved in cold TFA (0 °C) and stirred for 20 min. The solution was allowed to warm to room temperature and stirred for another 1 h. The reaction mixture was concentrated under reduced pressure, and the residue was dissolved in a minimal amount of MeOH. It was isolated by precipitation in cold diethyl ether (-20 °C) to yield 17.7 mg (68%) of an off-white solid: 
ESI-MS
Protein expression and labelling.
Creation of the gp45 mutant. The E212C mutant of gp45 was made using the Quickchange™ (Stratagene) mutagenesis method using the wild type gp45 gene cloned into the pet26b vector as a template. 4 The sequence of the forward mutagenic primer was 5'-GTGCTGCTAAATTTGAAGGTTGCCACGCGAATTATGTGGTAG-3' (the reverse primer was the reverse-complement of the forward primer).
Expression of the gp45 mutant. BL21(DE3) E. coli cells were transformed with a plasmid coding for the gp45 E212C mutant, grown to OD = 0.7, and induced with 0.4 mM IPTG. After 6 h the cells were pelleted, and the protein was purified as described previously. 5 Thiol and protein quantification. Ellman's test 6 trimer, as determined by UV spectroscopy (the porphyrin extinction coefficient in the storage buffer was determined to be ε = 116,000 M -1 cm -1 ) and Bradford assays. 6 In this particular case, protein loss due to precipitation was minimised by lowering the protein concentration from 120 to 45 µM and by adding DMSO up to a concentration of 10% v/v.
Furthermore, the conjugation buffer was supplemented with 100 mM potassium acetate to exchange the iodide counter ions of the porphyrin to acetate ions, and the incubation times was shortened to 3 h. The absorption maximum of the porphyrin Soret band in the UV-Vis was identical for the free and conjugated porphyrin, indicating that the porphyrin did not interact significantly with the protein itself. The protein was purified from unreacted labels by size exclusion chromatography (Fig. S5) . but it is the only of about 6 endonucleases in E. coli that degrade double stranded DNA in a non-specific manner. 8 Munn and Alberts have described the application of anion-exchange (MonoQ) chromatography to remove a nuclease contamination from their gp45 preparations. 9 Because of this, the labelled clamp proteins and all unlabelled E212C mutant stocks were purified using this procedure on a SourceQ column. 2. Experiments with octapeptide 3.
Design and rationale.
The binding of isolated gp45 clamp proteins to DNA is labile considering the processivity that is achieved by a completely formed clamp-polymerase complex. 10 It is indeed the interaction with other proteins which has been shown to lead to stable clamp-DNA complexes. For example, polymerase gp43 is bound to the clamp via its C-terminus, which is required for the formation of the polymerase holoenzyme. 11 The half-life of this complex on DNA is 7 -8 min (koff= 0.001 s -1 ). 12 Interaction between gp45 and gp43 already takes place in the absence of a DNA substrate (KD = 48 -480 nM). 13 Based on this interaction, we reasoned that a peptide analogue of the C-terminus interaction domain could 
ATPase stimulation assays.
The interaction between octapeptide 3 and gp45 was studied by the ATPase assay using a small forked DNA substrate, which mimics natural clamp loading sites (Fig. S7a) . Here, addition of gp43 inhibits the synergistic ATPase activity of gp44/62 in the presence of gp45 and a DNA substrate, indicative for the formation of the more stable holoenzyme complex on DNA. In this case, the ATP hydrolysis rate decreases because less loading events are necessary. However, if octapeptide 3 is able to meaningfully bind the gp45 clamp open subunit interface (as shown in Fig. S6b) then the ATP hydrolysis rate should also decrease when 3 is titrated into the solution, but for a different reason: less loading events are possible if the clamp is in its closed conformation. It was indeed found that less loading events took place. The ratio between the initial ATPase activity and measured activity (the shutdown ratio) was plotted against the concentration of the peptides and is shown in Fig. S7b . These curves could be fitted to a 1:1 binding model, resulting in a dissociation constant of 1.59 ± 0.04 µM.
An alternate interpretation of this data is that the loaded clamp may be more strongly associated with its DNA template when the peptide 'closes' it after loading, making the reloading of dissociated clamps more rare. This would mimic the mechanism by which polymerase gp43 stabilises the clamp. Berdis et al. 11 have made this implausible by using a DNA substrate without physical barriers to prevent translocation of the clamp off of the DNA. In this case, a more stable DNA/clamp association would not result in diminished ATPase activity, since the stabilised clamp can freely fall off the far end of the DNA template, making it newly available for reloading (in contrast, in our assay the clamp cannot fall off of the DNA because one site is blocked by the forked overhang, and the other side is blocked by a bulky streptavidin label, as shown in 
Experimental procedure.
ATPase assays were performed in a 2x10 mm cuvette at 25 °C. First, 60 µL of the ATP hydrolysis mix ( µL MilliQ and 1.7 µL gp44/62 solution (9.7 µM) were added and incubated for 3 min, while the absorption of NADH was monitored at 340 nm. Then, 1.5 µL gp45 solution (49 µM) was added and the solution was incubated for at least three minutes before 1.9 µL forked DNA template (Bio62/34/36, 40 µM) was added. Finally, 15 µL gp43 solution (9 µM) was added. ATPase rates were calculated by fitting linear parts of the measured decrease of the absorbance at 340 nm as a function of time by using the least squares method. Rates were converted to nM s -1 by multiplying the rate in Abs/min with 2679.5 (= 10 9 / 60 / εNADH), in which εNADH = 6220 M -1 cm -1 .
Final concentrations were 250 nM gp44/62, gp45 and DNA template, and various amounts of 3. Dilution of the ATPase mixture up to the final concentrations obtained in the experiments with the peptide did not significantly change the ATP hydrolysis rate.
See section 3.3 for more experiments involving octapeptide 3.
3. Oxidation experiments.
DNA templates.
The plasmid used for oxidation experiments was a pGEM plasmid with a T4 genomic insert 16 (3540 bp), which was purified using Qiagen maxiprep protocols. In experiments where a nicked plasmid was used as starting material, the nick was introduced by Nb.BbvCI (New England Biolabs) as described below, followed by purification through phenol chloroform extraction and ethanol precipitation. 
Sequence of the final plasmid:
GGGCGAATTGGGCCCGACGTCGCATGCTCCCGGCCGCCATGGCCGCGGGATATGCTATATCTCATTATTT TCCAGCCTCAAATGCTCGCATGTCTTGAATATGCTTAATAGCAAATCCACGTGATTTAATAGCATCAAGA  GCTCCGCTACAGAAATCTAATAAAATCCCCCAATACTGCAACGAGGTATCAACCTTTAAAACATCCTTAT  CCGCTGATAGAACTGTCTTCATTTCTGATTTCTCGTAACGATCCATACTAAATTCATCACCATCTCCTCG  TCCCGAGTAGTAGTCTAATCTAGCTTTAAGAGCAACTTTTTTCTGTGCTTCAATTCTAAGCATTTCCTTT  TTAATACTTGAATGCTTATTAAGCCATTTACTATATAACATCACATTATTAGCTGCTTCATACTGTAATT  TAGTCGAATCTATAAACACATCTTTCTTCAATTCTTCTTGAAGATCTTCTAATCTCATATTGTTCTCTAT  TCAATTGTTATTGGTTGTTATTGGATGGACTTAGATTCATTATACCACGTTTTAACGTGAAGCATTATAC  TCTATTACTGGAAGCCAGCTGCAGTTTTATCATCACTAGTGCGGCCGCCTGCAGGTCGACCATATGGGAG  AGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATG  GTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATA TCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCG  TATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTA  TCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAG  CAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCC  CCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATAC  CAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGT  CCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTA  GGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGT  AACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGA  TTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAG  AAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGA  TCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAA  AAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTA  AGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTT  AAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTA  CCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACG  GGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTA  TCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCC  AGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGC  CATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGA  TCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTG  TCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCAT  GCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGG  CGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGC  TCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGAT  GTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAA  ACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCC  TTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTA  GAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGATGCGGTGTGAAATACC  GCACAGATGCGTAAGGAGAAAATACCGCATCAGGAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGT  TAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAA  AGAATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGAC  TCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAA  GTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTG  ACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAGGGCGCTG  GCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGT  CCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAG  CTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTT  GTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATA The nicking site for the two BbvCI isoschizomers is bold and underlined. AAA-sites (and their complementary TTTsites) are highlighted with a grey background. The high incidence of AAA-sites, combined with their relatively homogenous distribution over the entire plasmid, makes it implausible that an unassociated catalyst would oxidise neighbouring reactive sites through distributive catalysis for lack of other substrates.
Oxidation experiments.
All oxidation reactions were carried out at room temperature in a 25 mM Tris•HOAc buffer, pH 7.5, with 150 mM KOAc and 10 mM Mg(OAc)2. Concentrations described in the protocols below are final concentrations at the start of the oxidation (i.e. after addition of the oxygen donor KHSO5). Oxidation reactions were quenched by the addition of HEPES•KOH pH 7.6 buffer to a final concentration of 150 mM, and extracted with 2 volumes of phenol / chloroform solution (1:1 v/v). The aqueous fraction was isolated and used for analysis. Samples from oxidation experiments were analysed on a 0.8% ethidium bromide-stained agarose gel made with 0.5x or 1x TBE buffer and ran at ~80 mA. As a molecular weight marker, λ-DNA / HindIII digest (NEB) was used. When indicated, BSA that was specifically treated to remove nuclease contaminations (NEB) was added to prevent non-specific absorption.
Oxidation of supercoiled DNA by Mn-TMPyP 1 (Fig. 2) . Supercoiled plasmid (200 ng, 25 ng mL -1 ) was oxidised by 50 nM Mn-TMPyP 1 in the presence of 0.4 µM KHSO5, in 37.5 mM phosphate buffer pH 7.5, containing 100 mM NaCl in a final total volume of 60 µL. The oxidation was performed at 0 °C for 1 min. It was quenched by the addition of 30 mM HEPES buffer pH 7.4 (final concentration). The plasmids were then biotinylated as described below.
Oxidation of supercoiled DNA by the catalytic clamp using varying oxygen donor concentrations (Fig. S8) Biotinylation and AFM-analysis of 1-oxidised plasmids (Fig. 2) . ARP 4 was added to a final concentration of 5 mM and the mixture was incubated for 1.5 h, after which a small amount of NaCNBH3 was added and the solution was incubated for another 15 min. The reaction mixture was purified with the help of a G25 spin column. The purified solution was buffered with AFM buffer (40 mM HEPES pH 7.4, 10 mM MgCl2) (final concentration) and supplemented with 1 µL of a 50 µM streptavidin solution (a 50 fold excess relative to the total amount of AAA sites in the DNA). This solution was incubated for 1 h, and subjected to a Sephadex G100 column equilibrated in AFM buffer. Proteincontaining fractions were identified using the Bradford assay. 6 A sample (4 µL) of the first protein-containing fraction was incubated for 5 min on freshly cleaved mica, washed with 1 mL MilliQ water, dried by air flow and analysed by AFM.
Oxidation of supercoiled DNA by the catalytic clamp (Fig. 3) . The catalytic clamp, at a concentration of 400 nM, was incubated with supercoiled plasmid (25 ng µL -1 ) in the presence of 50 µg mL -1 BSA. When indicated, peptide 3 (10 µM) was added. After 5 mins, the reaction was started by the addition of KHSO5 to a final concentration of 5 µM, bringing the total volume of the reaction to 60 µL. At the indicated times, the reactions were quenched, extracted, and analysed by SDS-PAGE or by AFM as described below. Biotinylation and AFM-analysis of catalytic clamp-oxidised plasmids (Fig. 3 and Fig. 5 ). Quenched samples from the catalytic clamp oxidation reactions were incubated with 4 mM ARP reagent 4, biotinylating aldehydes in DNA with a sensitivity of down to 2.4 aldehydes per 10 7 base pairs. 17 After 1.5 h, the amination reaction was quenched by the addition of a dilute NaCNBH3 solution. The reactions were then incubated for 15 min, and the DNA was precipitated in ethanol by addition of 0.1 volume 3 M NaOAc pH 5.3 and 2.5 volumes EtOH, followed by incubation at -20 °C for 30 min. The solutions were then centrifuged at 13,000 rpm for 15 min after which the pellets were resuspended in ice cold EtOH (70%) followed by an additional 10 min of centrifugation. The pellets were then dried in air and dissolved in AFM buffer (40 mM HEPES pH 7.4, 10 mM MgCl2), and 10 fold of streptavidin was added per total amount of potential oxidation sites (~190 per plasmid). After the addition of streptavidin, the samples were incubated for another 30 min before they were purified from excess streptavidin by a G100 sephadex column equilibrated in AFM buffer. The fraction with the highest amount of DNA was analysed by AFM. A sample (2 µL) of the first protein-containing fraction was incubated for 5 min on freshly cleaved mica, washed with 1 mL MilliQ water, dried by air flow and analysed by AFM. For Fig. 3b , 23 plasmids were analysed. For Fig. 5c, 13 Nt.BbvCI-nicked plasmids and 15 Nb.BbvCI-nicked plasmids were analysed. Please note that circular plasmids may sometimes break and become linear during sample preparation for AFM analysis; linear plasmids were not necessarily formed by oxidative catalysis.
3.3
The spatial distribution of oxidation sites.
Background. in Fig. 3 , we compare results from oxidation experiments using the catalytic clamp without a loader complex present, so that any interaction between the plasmid and the catalytic clamp are spontaneous. The comparison is between experiments where octapeptide 3 was or was not present, and they both used pristine supercoiled plasmid as To substantiate our conclusions, we initially planned to perform the same reactions with an extended reaction time,
hoping to obtain plasmids with 4 to 6 labels that were oxidised in the presence of peptide 3. This would allow a direct comparison of label locations related to peptide presence: if the peptide indeed inhibits processivity, the reaction sites should be more uniformly distributed along the plasmid, as opposed to the observation of label clusters when the peptide is absent. Unfortunately, as shown in Fig. 3a , extending the reaction time to up to 15 minutes did not lead to at least a single nick in every plasmid. We therefore performed the experiment described below:
Macromolecular crowding does not increase the activity of the catalytic clamp (Fig. S9) . In an attempt to improve the activity of the catalytic clamp, we set out to use macromolecular crowding to promote the clamp's association with its plasmid substrate. For this, the catalytic clamp (final concentration 400 nM) was incubated with supercoiled plasmid Fig. S9 . This experiment is identical to that performed for Fig. 3a , except PEG was added. Unfortunately, macromolecular crowding caused by PEG did not increase the rate at which supercoiled plasmids were oxidised by the catalytic clamp. Based on the fits shown in Fig. S9b , it does not appear that further increasing the reaction time will lead to further oxidations. It is known that porphyrins that are activated by an oxygen donor such as KHSO5 can lose their catalytic activity if no substrate molecule is encountered. 18 It may well be that the catalytic clamp loses its catalytic activity before it can nick all supercoiled plasmids whenever octapeptide 3 is present. This precludes the achievement of plasmids carrying 4 to 6 streptavidin labels by merely prolonging the reaction time under these conditions.
Discussion of
Strategy for direct comparison of inter-oxidation distances.
Our AFM-based analysis method allowed the determination of whether oxidation events on plasmids in the absence of octapeptide 3 showed a tendency to cluster or not, even after only a small percentage of oxidations had taken place. We performed oxidation experiments on supercoiled plasmids by the catalytic clamp with or without 3 present, as described above in the experimental section for Fig. 3 . For each experiment, the inter-label distances on individual plasmids were measured and expressed as a fraction of total plasmid length (Fig. S10) . Our intention was to compare inter-label distances from the sets of plasmids oxidised with or without peptide 3 present. Because we assumed that both processive and random oxidation events could take place without 3, but only random oxidation events could take place with 3, we statistically compared only the smallest distances found for each plasmid. These smallest distances are most sensitive to the presence or absence of processive behaviour by the catalyst. For this comparison, we considered all plasmids that had 2 or more labels from reactions where 3 was present. For reaction without 3, we only considered plasmids bearing 2 or 3 labels. This allowed S23 an assessment of the effect of octapeptide 3 after an equal amount of conversion had taken place, independent of the time duration that the reaction was allowed to proceed. Example of how inter-label distances were measured and expressed: the total plasmid length (red + green distance) was defined as "1," and other path lengths were expressed as a fraction of this distance.
Supplementary
Data transformation allows direct comparison.
Because the number of observed oxidation events on different plasmids ranged from 2 to 4, these minimum distances could not be directly compared. Even for randomly distributed oxidations, the chance for a small distance between reaction sites rises with the number of oxidations, so that comparing a minimum distance from a doubly oxidised plasmid with a minimum distance from a triply oxidised plasmid is not a fair comparison. Therefore, prior to statistical analysis, we transformed all minimum distance values to the distribution of minimum distance values between 2 oxidations (See Fig. S11a for transformed values of all distances measured).
Intuitively, this would appear to simply be a matter of multiplying the minimum distances from the three-oxidation cases by 3/2 and those from the four-oxidation case by 4/2. This is indeed true for the largest minimum distances that can be obtained: for two oxidations, the largest possible fractional minimum distance is 1/2, for three oxidations it is 1/3 and for four oxidations it is 1/4. However, this is not true for smaller minimum distances. When placing 3 or 4 points on a circle in a random, uniform manner, the distances between these points are not themselves uniformly distributed. To find the required correct multiplication factors for all distances, we constructed lookup tables by computational simulation of the placement of n=2,3,4 points on a circle of length 3540 (the length in base pairs of the plasmids used in our experiments) and collecting and sorting the minimum distances found between the points (see Fig. S11b for cumulative distribution functions (CDFs) for n=2,3,4, see next section for programming code used). In this way, for example, the minimum distance of 0.3001, obtained for a three-oxidation plasmid could be transformed to 0.4949, corresponding to the situation of a two-oxidation plasmid.
After transforming all minimum distances in this manner to the two-oxidation case, we applied a two-sample one-sided Kolmogorov-Smirnov test 19 ( Fig. S11c) to the minimum distances in the 'with' and 'without' situations (We chose as null hypothesis (H0): The two sample sets are drawn from the same distribution; Alternative hypothesis (H1): The set of minimum distances obtained for plasmids that were oxidised in the absence of 3 is drawn from a distribution with smaller values than the set of minimum distances obtained for plasmids that were oxidised in the presence of 3). The outcome of the test is that H0 should be rejected (p=0.0008). Apart from the test, this result could also be inferred from the Q-Q plot 20 shown in Fig. S11d . We conclude that processive behaviour of the catalyst in the absence of octapeptide 3 is likely, based on the distances between oxidation sites measured by AFM, compared to distances found when 3 was present.
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A note on processive catalysis.
Sequentiality: a difference exists between sequential and hopping processive catalysis. In sequential processive catalysis, substrate sites are converted in order of occurrence, as is the case for, for example, DNA polymerases. When a hopping mechanism is followed, the catalyst remains bound but does not necessarily convert all substrate sites it passes, as is the case for porphyrin-capped clamp molecules. 21 If catalysis is slow and translocation speed is high, it may be expected that not all available reaction sites are converted, because the catalyst may pass one by without interacting with it. This leads to a hopping mechanism It is tempting to assume that for our system, because we observe clustered reaction sites, this is not the case and catalysis is faster than translocation, leading to sequential processive catalysis.
Unfortunately, this is not necessarily so, even though we observe a measure of sequentiality for some experiments. The catalytic clamp carries three porphyrins. These intercalate in the DNA at AAA-sites to perform their oxidative nicking.
This intercalation may well slow down or stall the translocation of the entire complex until oxidation is complete. The nicking significantly reduces the binding affinity of the porphyrin, practically freeing it up again. Thus, the very mechanism of oxidation may contribute to sequentiality. There are three catalysts that can each intercalate and thus influence the translocation, makes this more plausible. However, we have no experimental proof for this mechanism, so it remains conjecture from our part.
Sliding direction: when the clamp is loaded by the gp44/62 complex and guided in a specific direction, there is a theoretical possibility that it slides all the way around a plasmid to come back upon the 'blocked' side. This is highly unlikely: the T4 processivity factor is dynamic in character. When it is loaded upon a DNA strand, it can dissociate again. Recruiting a DNA polymerase stabilises the association, but our catalytic clamp does not do this (recruiting a polymerase stalls translocation if no actual polymerisation takes place). ATPase stimulation assays that measure the amount of clamp loading events achieve steady states, which indicates that clamps are continuously loaded onto DNA. This is only possible if they also dissociate. The fact that a clamp does not remain bound indefinitely makes it implausible that it would manage the entire round trip. Additionally, the directionality experiments had a defined duration (5 minutes). Since no more than eight oxidations were found in a single plasmid, the catalytic clamp probably travels a distance of no more than ~150 base pairs (the distance between the loading site and the 8 th AAA-site).
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